Amy Baxter
Staff ReporterAmy Baxter is a staff reporter for PharmaVoice. Before joining the team, she served as an editor and reporter in the B2B healthcare space for eight years at Health Exec and Home Health Care News. She also covered the retail industry as editor of Retail Leader, and hosted an Hermes award-winning weekly podcast and video interview series, Trend Talk, featuring industry executives and experts. A lifelong sailor, Amy has taken her media skills on the water to cover regattas and sailing events across the country. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Race to Mackinac Island. She is based in Florida.
135 articles by Amy Baxter
-
A brewing GLP-1 showdown, from Big Pharma pills to a biotech implant
Aug. 27, 2025 -
FDA’s new accelerated pathway could open pharma up to risks, as well as benefits
Aug. 25, 2025 -
MAHA leaders may take aim at pharma DTC advertising
Aug. 20, 2025 -
Despite FDA ruling, compounded GLP-1s are still giving Novo and Lilly headaches on the market
Aug. 18, 2025 -
With FDA PreCheck, drugmakers may get a manufacturing boost
Aug. 13, 2025 -
3 ways the GLP-1 market has changed shape this year
Aug. 12, 2025 -
Drugmakers score policy win in a prolonged fight against 340B
Aug. 4, 2025 -
Roche pushes ahead with late-comer strategy in obesity
July 30, 2025 -
FDA invites more data from abroad — with a wary eye on China
July 16, 2025 -
Need a DTC platform? Here’s how one company built its own.
July 14, 2025 -
As its cancer vaccine moves through the clinic, Transgene sets sights on manufacturing
July 9, 2025 -
GLP-1 roadblocks: Discontinuation rates soar as insurers clamp down
July 7, 2025 -
FDA’s new mission to speed drug reviews
June 30, 2025 -
After myriad failures, a new wave of ALS drugs approaches
June 25, 2025 -
Megablockbusters are the holy grail. Here’s how drugmakers are getting there.
June 23, 2025 -
Is DTC pharma advertising coming to an end?
June 18, 2025 -
Locked in a federal stalemate, states take PBM reform into their own hands
June 16, 2025 -
Pharma’s wins and losses in the budget bill
June 11, 2025 -
The biggest obesity deals of 2025 so far
June 9, 2025 -
FDA’s Elsa AI is here, and the industry has questions
June 5, 2025 -
The MAHA agenda won’t include expanding GLP-1 coverage — for now
June 2, 2025 -
What’s next for Trump’s ‘most favored nation’ policy?
May 27, 2025 -
Lilly’s former small molecule head makes the leap to a rising biotech in obesity
May 21, 2025 -
With the third round of Medicare price negotiations on the way, here’s how the policy is shifting
May 19, 2025 -
Trump’s ‘most favored nation’ policy is back. Here’s why it failed the first time.
May 14, 2025